Free Trial
The Market Does Not Wait. MarketBeat All Access Alerts for $149
Get the Alerts
Claim MarketBeat All Access Sale Promotion
OTCMKTS:MKGAF

Merck KGaA Q1 2024 Earnings Results & Report

Merck KGaA logo
$167.21 +9.24 (+5.85%)
As of 10/20/2026 03:55 PM Eastern

Merck KGaA missed analyst earnings expectations in its Q1 2024 results, released May 15, 2024. The company reported EPS of $1.74 versus the $1.92 consensus estimate, while revenue was $5.56 billion.

Earnings Announcement Details

Quarter
Q1 2024
Report Date

Merck KGaA EPS Results

Actual EPS
$1.74
Consensus EPS
$1.92
Beat/Miss
Missed by -$0.18
One Year Ago EPS
N/A

Merck KGaA Revenue Results

Actual Revenue
$5.56 billion
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Merck KGaA's next earnings date is estimated for Thursday, November 12, 2026, based on past reporting schedules.

Conference Call Resources

Merck KGaA Q1 2024 Earnings FAQ

Merck KGaA (OTCMKTS:MKGAF) reported earnings of $1.74 per share for Q1 2024, missing the consensus estimate of $1.92. The report was announced on Wednesday, May 15, 2024.

Merck KGaA reported revenue of $5.56 billion for Q1 2024.

Merck KGaA's next earnings date is estimated for Thursday, November 12, 2026. MarketBeat tracks confirmed and estimated earnings dates for Merck KGaA on the company's earnings history page.

Merck KGaA Earnings Headlines

Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.tc pixel
Merck KGaA (OTCMKTS:MKGAF) Shares Gap Down - Time to Sell?
See More Merck KGaA Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Merck KGaA? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Merck KGaA and other key companies, straight to your email.

About Merck KGaA

Merck KGaA (OTCMKTS:MKGAF) is a German science and technology company headquartered in Darmstadt, Germany. Founded in 1668, it is one of the world’s oldest operating pharmaceutical and chemical companies. The company operates under the name EMD Serono in the United States and Canada, where the Merck name is associated with a separate company.

Merck KGaA operates through three primary business sectors: Healthcare, Life Science and Electronics. Its Healthcare business develops and markets prescription medicines, including treatments in oncology, neurology and immunology, as well as fertility and other specialty-care products. The Life Science business supplies laboratory products, equipment, services and technologies used in pharmaceutical manufacturing, biotechnology, research and academic laboratories.

The Electronics business develops materials and solutions for the semiconductor and display industries, including specialty chemicals, semiconductor materials and liquid-crystal technologies. Merck KGaA serves customers in markets around the world through research, manufacturing and commercial operations across multiple regions. Belén Garijo has served as the company’s chief executive officer and chair of its executive board since 2021.

View Merck KGaA Profile